Carl Desantis
CIK: 0001102948
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)4 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INBP
INTEGRATED BIOPHARMA INC
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 15, 2026INBP
INTEGRATED BIOPHARMA INC
Gift(G)Indirect9M shares- - Apr 15, 2026INBP
INTEGRATED BIOPHARMA INC
Gift(G)Indirect2.2M shares- - Mar 24, 2026INBP
INTEGRATED BIOPHARMA INC
Gift(G)Indirect1.4M shares- - Mar 24, 2026INBP
INTEGRATED BIOPHARMA INC
Gift(G)Indirect7.4K shares-
1-4 of 4 transactions
About DESANTIS CARL
DESANTIS CARL (SEC CIK 0001102948) files insider reports with the SEC as 10% Owner of INTEGRATED BIOPHARMA INC (INBP).
Signal8 holds 2 ownership filings by DESANTIS CARL, all Form 4s, filed between Mar 26, 2026 and Apr 17, 2026. Those filings report 4 transactions, from Mar 24, 2026 to Apr 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DESANTIS CARL's filings is in DELRAY BEACH, FL.
Recent filings by DESANTIS CARL
Other insiders filing for INTEGRATED BIOPHARMA INC (INBP)
- Friedman Eric J, Director
- DeSantis Damon, Director
- Canarick Robert, Director
- Milmoe William H., Director
- KAY CHRISTINA, Co-Chief Executive Officer
- RIVA SHEPPARD, Co-Chief Executive Officer